Genomma Lab Internacional, S.A.B. de C.V.

BMV:LAB B Stock Report

Market Cap: Mex$15.5b

Genomma Lab Internacional. de Dividend

Dividend criteria checks 3/6

Genomma Lab Internacional. de is a dividend paying company with a current yield of 4.69% that is well covered by earnings.

Key information

4.7%

Dividend yield

68%

Payout ratio

Industry average yield2.3%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Earnings per shareMex$1.12
Dividend yield forecast in 3Y2.0%

Recent dividend updates

Recent updates

Here's Why Genomma Lab Internacional. de (BMV:LABB) Can Manage Its Debt Responsibly

Jan 29
Here's Why Genomma Lab Internacional. de (BMV:LABB) Can Manage Its Debt Responsibly

Is Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Trading At A 49% Discount?

Nov 07
Is Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Trading At A 49% Discount?

Is Genomma Lab Internacional. de (BMV:LABB) Using Too Much Debt?

Mar 31
Is Genomma Lab Internacional. de (BMV:LABB) Using Too Much Debt?

Is Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Trading At A 32% Discount?

Feb 24
Is Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Trading At A 32% Discount?

Does Genomma Lab Internacional. de (BMV:LABB) Have A Healthy Balance Sheet?

Dec 07
Does Genomma Lab Internacional. de (BMV:LABB) Have A Healthy Balance Sheet?

Rainbows and Unicorns: Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Analysts Just Became A Lot More Optimistic

Sep 24
Rainbows and Unicorns: Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Analysts Just Became A Lot More Optimistic

Analysts Just Made A Major Revision To Their Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Revenue Forecasts

Aug 01
Analysts Just Made A Major Revision To Their Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Revenue Forecasts

Genomma Lab Internacional. de (BMV:LABB) Has A Pretty Healthy Balance Sheet

Jul 27
Genomma Lab Internacional. de (BMV:LABB) Has A Pretty Healthy Balance Sheet

Here's Why Genomma Lab Internacional. de (BMV:LABB) Can Manage Its Debt Responsibly

Mar 22
Here's Why Genomma Lab Internacional. de (BMV:LABB) Can Manage Its Debt Responsibly

Are Investors Undervaluing Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) By 44%?

Feb 15
Are Investors Undervaluing Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) By 44%?

Genomma Lab Internacional. de (BMV:LABB) Seems To Use Debt Quite Sensibly

Nov 24
Genomma Lab Internacional. de (BMV:LABB) Seems To Use Debt Quite Sensibly

Here's Why I Think Genomma Lab Internacional. de (BMV:LABB) Is An Interesting Stock

Sep 08
Here's Why I Think Genomma Lab Internacional. de (BMV:LABB) Is An Interesting Stock

Genomma Lab Internacional, S.A.B. de C.V.'s (BMV:LABB) Intrinsic Value Is Potentially 96% Above Its Share Price

Jun 10
Genomma Lab Internacional, S.A.B. de C.V.'s (BMV:LABB) Intrinsic Value Is Potentially 96% Above Its Share Price

Is Genomma Lab Internacional. de (BMV:LABB) A Risky Investment?

May 24
Is Genomma Lab Internacional. de (BMV:LABB) A Risky Investment?

Should You Be Adding Genomma Lab Internacional. de (BMV:LABB) To Your Watchlist Today?

May 06
Should You Be Adding Genomma Lab Internacional. de (BMV:LABB) To Your Watchlist Today?

Investors Who Bought Genomma Lab Internacional. de (BMV:LABB) Shares Five Years Ago Are Now Up 65%

Mar 13
Investors Who Bought Genomma Lab Internacional. de (BMV:LABB) Shares Five Years Ago Are Now Up 65%

Genomma Lab Internacional. de (BMV:LABB) Has A Pretty Healthy Balance Sheet

Feb 19
Genomma Lab Internacional. de (BMV:LABB) Has A Pretty Healthy Balance Sheet

Do Its Financials Have Any Role To Play In Driving Genomma Lab Internacional, S.A.B. de C.V.'s (BMV:LABB) Stock Up Recently?

Feb 02
Do Its Financials Have Any Role To Play In Driving Genomma Lab Internacional, S.A.B. de C.V.'s (BMV:LABB) Stock Up Recently?

Are Investors Undervaluing Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) By 42%?

Jan 15
Are Investors Undervaluing Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) By 42%?

What Is The Ownership Structure Like For Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB)?

Dec 28
What Is The Ownership Structure Like For Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB)?

Genomma Lab Internacional. de (BMV:LABB) Shareholders Have Enjoyed A 54% Share Price Gain

Dec 10
Genomma Lab Internacional. de (BMV:LABB) Shareholders Have Enjoyed A 54% Share Price Gain

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Whilst dividend payments have been stable, LAB B has been paying a dividend for less than 10 years.

Growing Dividend: LAB B's dividend payments have increased, but the company has only paid a dividend for 2 years.


Dividend Yield vs Market

Genomma Lab Internacional. de Dividend Yield vs Market
How does LAB B dividend yield compare to the market?
SegmentDividend Yield
Company (LAB B)4.7%
Market Bottom 25% (MX)2.2%
Market Top 25% (MX)6.6%
Industry Average (Pharmaceuticals)2.3%
Analyst forecast in 3 Years (LAB B)2.0%

Notable Dividend: LAB B's dividend (4.69%) is higher than the bottom 25% of dividend payers in the MX market (2.17%).

High Dividend: LAB B's dividend (4.69%) is low compared to the top 25% of dividend payers in the MX market (6.56%).


Earnings Payout to Shareholders

Earnings Coverage: With its reasonable payout ratio (67.6%), LAB B's dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its reasonably low cash payout ratio (41.6%), LAB B's dividend payments are well covered by cash flows.


Discover strong dividend paying companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.